PubMed Philp, D., Badamchian, M., Scheremeta, B., Nguyen, M., Goldstein, A.L., Kleinman, H.K
Results can vary from person to person
Oral semaglutide may be worth a conversation with a provider in specific situations: Patients with type 2 diabetes who are candidates for semaglutide and strongly prefer not to inject Patients with a documented needle phobia or significant injection anxiety You want to explore a lower-exposure option before committing to injectables, or are curious about what compounded semaglutide looks like as an alternative starting point It is generally not the primary recommendation for patients whose sole goal is significant weight loss, given the current dose ceiling and absorption variability
FEBS Lett 211(2):169174 Holter MM, Saikia M, Cummings BP (2022) Alpha-cell paracrine signaling in the regulation of beta-cell insulin secretion
Central appetite regulation : GLP-1 receptor agonists act on appetite centres in the brain, reducing hunger and food intake, which contributes to weight loss